The estimated Net Worth of Joseph Michael Warusz is at least $44.6 Thousand dollars as of 22 December 2014. Joseph Warusz owns over 8,265 units of Soligenix Inc stock worth over $44,565 and over the last 13 years Joseph sold SNGX stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Joseph Warusz SNGX stock SEC Form 4 insiders trading
Joseph has made over 2 trades of the Soligenix Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Joseph bought 8,265 units of SNGX stock worth $10,001 on 22 December 2014.
The largest trade Joseph's ever made was buying 8,265 units of Soligenix Inc stock on 22 December 2014 worth over $10,001. On average, Joseph trades about 1,439 units every 24 days since 2011. As of 22 December 2014 Joseph still owns at least 12,955 units of Soligenix Inc stock.
You can see the complete history of Joseph Warusz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Joseph Warusz's mailing address?
Joseph's mailing address filed with the SEC is 29 EMMONS DRIVE, SUITE C-10, , PRINCETON, NJ, 08540.
Insiders trading at Soligenix Inc
Over the last 15 years, insiders at Soligenix Inc have traded over $502,220 worth of Soligenix Inc stock and bought 775,279 units worth $1,096,136 . The most active insiders traders include Randal Jintrexon Corp Kirk, Jerome B Zeldis, and Spacavazza Paolo Leadiant B.... On average, Soligenix Inc executives and independent directors trade stock every 115 days with the average trade being worth of $91,349. The most recent stock trade was executed by Richard Straube on 18 May 2022, trading 8,000 units of SNGX stock currently worth $4,000.
What does Soligenix Inc do?
soligenix, inc. is a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous t-cell lymphoma, oral mucositis, pediatric crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.
What does Soligenix Inc's logo look like?
Complete history of Joseph Warusz stock trades at Soligenix Inc
Soligenix Inc executives and stock owners
Soligenix Inc executives and other stock owners filed with the SEC include:
-
Dr. Christopher J. Schaber Ph.D.,
Chairman, CEO & Pres -
Christopher Schaber,
Chairman of the Board, President, Chief Executive Officer -
Dr. Oreola Donini Ph.D.,
Sr. VP & Chief Scientific Officer -
Oreola Donini,
Senior Vice President, Chief Scientific Officer -
Dr. Richard C. Straube M.D., MSc.,
Sr. VP & Chief Medical Officer -
Jonathan L. Guarino CPA, CGMA,
Sr. VP, CFO & Corp. Sec. -
Richard Straube,
Senior Vice President and Chief Medical Officer -
Jonathan Guarino,
Chief Financial Officer, Senior Vice President, Corporate Secretary -
Jerome Zeldis,
Independent Director -
Robert Rubin,
Independent Director -
Diane Parks,
Independent Director -
Gregg Lapointe,
Independent Director -
Richard L. Dunning,
Exec. Officer -
Marco Maria Brughera,
Director -
Keith L Brownlie,
Director -
Karen R Krumeich,
SVP and CFO -
Joseph Michael Warusz,
VP of Finance/Acting CFO -
Randal Jintrexon Corp Kirk,
-
Spacavazza Paolo Leadiant B...,
-
Mark E. Pearson,
Director -
Kevin Horgan,
Senior VP; Chief Med Officer -
Virgil Thompson,
Director -
Tamar D Howson,
Director -
Management Llc Berman Ross ...,
-
Robert N Brey,
Chief Science Officer & Sr VP -
Paolo Cavazza,
10% owner -
Evan Myrianthopoulos,
CFO and Senior Vice Presient -
Brian L Hamilton,
Chief Medical Officer & Sr VP -
Christopher P. Schnittker,
VP-Admin., Controller -
Tau Finanziaria Spasigma Ta...,
-
Claudio Cavazza,
10% owner -
Timothy R. Cote,